Massachusetts Financial Services Co. MA Boosts Position in Integer Holdings Corporation $ITGR

Key Points

• Massachusetts Financial Services Co. MA raised its stake in Integer by 98.8% in Q4 to 806,982 shares (about 2.30% ownership), valued at roughly $63.29 million.
• Integer beat Q4 estimates with $1.76 EPS vs. $1.70 consensus and $472.06M revenue, set FY2026 guidance of 6.290–6.780 EPS, while analysts carry a consensus "Hold" rating and a $102 price target.
• The stock trades around $88.67 with a market cap of about $3.02 billion and a P/E of 30.9, and institutional investors own 99.29% of the shares.

Massachusetts Financial Services Co. MA raised its stake in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 98.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 806,982 shares of the medical equipment provider's stock after buying an additional 401,121 shares during the quarter. Massachusetts Financial Services Co. MA owned about 2.30% of Integer worth $63,292,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of ITGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Integer by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider's stock valued at $2,539,000 after acquiring an additional 837 shares during the last quarter. Millennium Management LLC boosted its position in shares of Integer by 2,408.8% during the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider's stock valued at $14,531,000 after acquiring an additional 118,224 shares during the last quarter. Jones Financial Companies Lllp boosted its position in shares of Integer by 79,888.9% during the 1st quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider's stock valued at $850,000 after acquiring an additional 7,190 shares during the last quarter. United Services Automobile Association bought a new stake in shares of Integer during the 1st quarter valued at about $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Integer by 4.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider's stock valued at $12,900,000 after acquiring an additional 4,873 shares during the last quarter. Institutional investors own 99.29% of the company's stock.

Integer Stock Performance

NYSE:ITGR opened at $88.67 on Wednesday. The business has a 50 day moving average of $85.87 and a 200 day moving average of $82.88. The company has a market capitalization of $3.02 billion, a price-to-earnings ratio of 30.90, a PEG ratio of 1.48 and a beta of 0.71. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $127.56. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.23.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share for the quarter, topping analysts' consensus estimates of $1.70 by $0.06. The company had revenue of $472.06 million during the quarter, compared to the consensus estimate of $462.73 million. Integer had a return on equity of 13.26% and a net margin of 5.55%.Integer's quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.43 EPS. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. On average, sell-side analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, VP Tommy P. Thomas sold 825 shares of the business's stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the sale, the vice president owned 4,381 shares in the company, valued at $372,385. The trade was a 15.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 2.16% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Citigroup lifted their price target on Integer from $75.00 to $92.00 and gave the company a "neutral" rating in a research report on Friday, February 20th. Raymond James Financial reiterated an "outperform" rating and set a $101.00 price target on shares of Integer in a research report on Monday, February 23rd. Wall Street Zen downgraded Integer from a "buy" rating to a "hold" rating in a research report on Sunday, January 25th. Wells Fargo & Company lifted their price target on Integer from $72.00 to $84.00 and gave the company an "equal weight" rating in a research report on Friday, February 20th. Finally, Truist Financial lifted their price target on Integer from $95.00 to $97.00 and gave the company a "buy" rating in a research report on Friday, February 20th. Four research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, Integer currently has an average rating of "Hold" and a consensus price target of $102.00.

Integer Company Profile

Integer Holdings Corporation NYSE: ITGR is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.